Astrazeneca approaches Gilead about potential merger
![Foto: Mike Blake/REUTERS / X00030](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12198855.ece/ALTERNATES/schema-16_9/doc7axae8u5afcs69x93l9.jpg)
Astrazeneca has made a preliminary approach to rival drugmaker Gilead Sciences about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal on record.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.